Clinical Reflections®: Reflecting on Missed Opportunities in Nontuberculous Mycobacteria Lung Disease

Program Overview

Nontuberculous mycobacteria lung disease (NTM-LD) is a relatively uncommon condition, although its prevalence is rising. In this interactive CME activity, Drs. Anne O’Donnell and Patrick Flume review 2 patient cases to demonstrate how clinicians can maintain a greater index of suspicion for the diagnosis of NTM-LD to enable timely and effective therapy. The management of NTM-LD remains challenging, owing to the need for long-term treatment, the potential for drug-related toxicities and patient nonadherence. These factors underscore the importance of specialty referral for the successful management of NTM-LD.

Credit Expired
CE Credit Expired
Expires: December 25, 2020

Target Audience

The target audience for this activity is US-based pulmonologists and infectious disease specialists.

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the current epidemiologic trends and burdens posed by nontuberculous mycobacteria lung disease (NTM-LD) and its treatment
  • Implement recommended diagnostic practices for NTM-LD based on the identification of at-risk patients
  • Institute best practices for NTM-LD management with available treatment options, including proactive monitoring for adverse events and adherence to existing and new treatments

Activity Faculty


Anne E. O'Donnell, MD

Professor, Medicine
Nehemiah and Naomi Cohen Chair, Pulmonary Disease Research
Chief, Division of Pulmonary, Critical Care and Sleep Medicine
Georgetown University Hospital
Washington, DC


Patrick A. Flume, MD

Professor, Medicine and Pediatrics
Powers Huggins Endowed Chair, Cystic Fibrosis
Medical University of South Carolina
Charleston, SC

Supporter Statement

Provider Statement

Disclosure of Financial Relationships


Planners and Managers

Method of Participation and Request for Credit

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | | (866) 770-RMEI


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources